Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Dynorphin and the pathophysiology of drug addiction.

Shippenberg TS, Zapata A, Chefer VI.

Pharmacol Ther. 2007 Nov;116(2):306-21. Epub 2007 Jul 24. Review.

2.

Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.

Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben-Shahar O, Angeletti S, Richter RR.

Ann N Y Acad Sci. 2001 Jun;937:1-26. Review.

PMID:
11458532
3.

Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.

Koob GF.

Psychopharmacology (Berl). 2017 May;234(9-10):1315-1332. doi: 10.1007/s00213-016-4484-6. Epub 2017 Jan 3. Review.

PMID:
28050629
4.

κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction.

Butelman ER, Yuferov V, Kreek MJ.

Trends Neurosci. 2012 Oct;35(10):587-96. doi: 10.1016/j.tins.2012.05.005. Epub 2012 Jun 16. Review.

5.

Addiction as a stress surfeit disorder.

Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, Schmeichel B, Vendruscolo LF, Wade CL, Whitfield TW Jr, George O.

Neuropharmacology. 2014 Jan;76 Pt B:370-82. doi: 10.1016/j.neuropharm.2013.05.024. Epub 2013 Jun 6. Review.

6.

kappa-Opioid receptor signaling and brain reward function.

Bruijnzeel AW.

Brain Res Rev. 2009 Dec 11;62(1):127-46. doi: 10.1016/j.brainresrev.2009.09.008. Epub 2009 Oct 2. Review.

7.

Neuropharmacology of cocaine and ethanol dependence.

Koob GF, Weiss F.

Recent Dev Alcohol. 1992;10:201-33. Review.

PMID:
1350359
8.

The "ups and downs" of signaling cascades in addiction.

Ron D, Jurd R.

Sci STKE. 2005 Nov 8;2005(309):re14. Review.

PMID:
16278489
9.

Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.

Patrono E, Gasbarri A, Tomaz C, Nishijo H.

Med Hypotheses. 2016 Aug;93:62-70. doi: 10.1016/j.mehy.2016.05.015. Epub 2016 May 17.

10.

Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.

Shippenberg TS, LeFevour A, Chefer VI.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):442-53. Review.

11.

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Bruchas MR, Land BB, Chavkin C.

Brain Res. 2010 Feb 16;1314:44-55. doi: 10.1016/j.brainres.2009.08.062. Epub 2009 Aug 28. Review.

12.

Cocaine addiction as a neurological disorder: implications for treatment.

Majewska MD.

NIDA Res Monogr. 1996;163:1-26. Review.

PMID:
8809851
13.

The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Yoo JH, Kitchen I, Bailey A.

Br J Pharmacol. 2012 Aug;166(7):1993-2014. doi: 10.1111/j.1476-5381.2012.01952.x. Review.

14.

Addictions and stress: clues for cocaine pharmacotherapies.

Picetti R, Schlussman SD, Zhou Y, Ray B, Ducat E, Yuferov V, Kreek MJ.

Curr Pharm Des. 2013;19(40):7065-80. Review.

PMID:
23574443
15.

Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems.

Shippenberg TS, Chefer VI, Zapata A, Heidbreder CA.

Ann N Y Acad Sci. 2001 Jun;937:50-73. Review.

PMID:
11458540
16.

Review. Neurobiological mechanisms for opponent motivational processes in addiction.

Koob GF, Le Moal M.

Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3113-23. doi: 10.1098/rstb.2008.0094. Review.

18.

Neurocircuitry of alcohol addiction: synthesis from animal models.

Koob GF.

Handb Clin Neurol. 2014;125:33-54. doi: 10.1016/B978-0-444-62619-6.00003-3. Review.

PMID:
25307567
19.

The neural basis of drug craving: an incentive-sensitization theory of addiction.

Robinson TE, Berridge KC.

Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91. Review.

20.

Stress, habits, and drug addiction: a psychoneuroendocrinological perspective.

Schwabe L, Dickinson A, Wolf OT.

Exp Clin Psychopharmacol. 2011 Feb;19(1):53-63. doi: 10.1037/a0022212.

PMID:
21341923

Supplemental Content

Support Center